Science Explorer Back to mapMap
Discussion
Researcher · Oncomedics (France) · France

Damien France

Damien France publishes mostly in Immunology, Oncology and Biotechnology, on topics such as Cancer Research and Treatments, Immunotherapy and Immune Responses and Nanoplatforms for cancer theranostics.

OpenAlex
World rank
#5,045,266
of 7,710,434 ranked researchers
Rank in France
#212,866
of 324,115
Works
16
Citations
6
Citations per work
0.4
h-index
1
i10-index 0Top 99.8% in Immunology
Damien France

What does Damien France research?

Damien France's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (20%).

Life Sciences: 8 works · 50.0% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 29.5% of their workBiotechnology: 3 works · 15.9% of their workCancer Research: 1 works · 6.8% of their workMolecular Biology: 1 works · 6.8% of their workImmunology and Microbiology: 3 works · 20.5% of their workImmunology: 3 works · 20.5% of their workHealth Sciences: 5 works · 29.6% of their workMedicine: 5 works · 29.6% of their workOncology: 3 works · 18.2% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 11.4% of their workEverything else: 3 works · 20.4% of their workTHEIR WORKDamien France16works
Life Sciences50%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology529.5%
    2. Immunology and Microbiology320.5%
    1. Medicine529.6%
  3. Everything else320.4%
  1. 1Immunology20% of their works
  2. 2Oncology18% of their works
  3. 3Biotechnology16% of their works
  4. 4Radiology, Nuclear Medicine and Imaging11% of their works
  5. 5Cancer Research7% of their works
  6. 6Molecular Biology7% of their works

Research topics

Which keywords describe Damien France's research?

The keywords of their largest research topics: Immunotherapy, Tumor Targeting, Gene Therapy, Arginine Deprivation, Bacterial Therapy, Immunity, Cancer Immunotherapy and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immunotherapy102 topics
  2. Tumor Targeting102 topics
  3. Gene Therapy92 topics
  4. Arginine Deprivation71 topic
  5. Bacterial Therapy71 topic
  6. Immunity62 topics
  7. Cancer Immunotherapy41 topic
  8. Dendritic Cells41 topic
  9. Immune Checkpoint Blockade31 topic
  10. Nanoparticles31 topic
  11. PD-1 and PD-L131 topic
  12. Photothermal Therapy31 topic
  13. AAV21 topic
  14. Activation21 topic
  15. Cancer Genomics21 topic
  16. Fc Receptors21 topic
  17. Macrophage21 topic
  18. Mutational Signatures21 topic
  19. Therapeutic Antibodies21 topic
  20. Viral Vectors21 topic

Where does Damien France work?

Damien France's main affiliation in the publication record is Oncomedics (France), France.

How many publications and citations does Damien France have?

OpenAlex counts 16 works and 6 citations for Damien France, an h-index of 1, ranking #5,045,266 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Damien France. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.